Recombinant Dog E-Selectin/CD62E Protein，His

E-Selectin, also known as CD62E, is a cell adhesion molecule predominantly expressed on activated endothelial cells. It plays a crucial role in the inflammatory response by mediating the tethering and rolling of leukocytes on the endothelium during the early stages of immune response. E-Selectin binds to specific carbohydrate ligands on leukocytes, facilitating their migration from the bloodstream to sites of inflammation or injury. Given its significant role in various pathological conditions, including atherosclerosis, chronic inflammatory diseases, and cancer metastasis, E-Selectin has become a target for therapeutic interventions. The study of E-Selectin at the molecular level, particularly through the development of recombinant protein forms, allows for a better understanding of its structure-function relationships and interaction dynamics with ligands. This research can pave the way for novel anti-inflammatory therapies and drug delivery systems that can selectively target activated endothelial cells, thereby enhancing treatment efficacy while minimizing side effects. The generation and characterization of E-Selectin/CD62E recombinant proteins enable detailed investigations into its role in immune responses, and potential applications in diagnostic and therapeutic settings are being explored as researchers aim to translate these findings into clinical applications.